| Literature DB >> 17978032 |
Tritia R Yamasaki1, Mathew Blurton-Jones, Debbi A Morrissette, Masashi Kitazawa, Salvatore Oddo, Frank M LaFerla.
Abstract
Neuronal loss is a major pathological outcome of many common neurological disorders, including ischemia, traumatic brain injury, and Alzheimer disease. Stem cell-based approaches have received considerable attention as a potential means of treatment, although it remains to be determined whether stem cells can ameliorate memory dysfunction, a devastating component of these disorders. We generated a transgenic mouse model in which the tetracycline-off system is used to regulate expression of diphtheria toxin A chain. After induction, we find progressive neuronal loss primarily within the hippocampus, leading to specific impairments in memory. We find that neural stem cells transplanted into the brain after neuronal ablation survive, migrate, differentiate and, most significantly, improve memory. These results show that stem cells may have therapeutic value in diseases and conditions that result in memory loss.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17978032 PMCID: PMC6673368 DOI: 10.1523/JNEUROSCI.1627-07.2007
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167